"Houston Eye Associates (HEA) is a team of board-certified ophthalmologists and board-licensed optometrists with advanced fellowship and specialty training in the fields of ophthalmology and optometry. For 50 years Houston Eye has been providing patients with the highest level of care at over 21 locations in Greater Houston. HEA covers all areas of ophthalmological and optometric care, with treatment available in all specialties and ages. Specialties include: LASIK/refractive surgery, cataracts, glaucoma, retina, oculoplastic, uveitis and neuro-ophthalmology. HEA also has an optical center that specializes in vison correction with state-of-the-art ophthalmic lenses and custom contact lenses. Houston Eye Associates is more than just eye exams"

During the past decade, Houston Eye Associates HEA - Gramercy Location conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Eye Associates HEA - Gramercy Location" #1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Houston Eye Associates HEA - Gramercy Location" are "Dry Eye Syndrome" (2 trials), "Dry Eye" (1 trials), "Glaucoma and Ocular Hypertension" (1 trials) and "Neurotrophic Keratitis" (1 trials). Many other conditions were trialed in "Houston Eye Associates HEA - Gramercy Location" in a lesser frequency.

Most popular intervention types in "Houston Eye Associates HEA - Gramercy Location" are "Drug" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Vehicle" (4 trials), "Oxervate" (2 trials), "DE-117 Ophthalmic Solution" (1 trials), "Timolol Maleate Ophthalmic Solution 0.5%" (1 trials) and "Udonitrectag" (1 trials). Other intervention names were less common.

The vast majority of trials in "Houston Eye Associates HEA - Gramercy Location" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Houston Eye Associates HEA - Gramercy Location". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Houston Eye Associates HEA - Gramercy Location, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Houston Eye Associates HEA - Gramercy Location, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".